MIM
IBB icon

MPI Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

MPI Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2M Buy
+18,747
New +$2M 2.4% 17

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MPI Investment Management's IBB Position: Q4 2017 in Review

MPI Investment Management opened a new position in iShares Biotechnology ETF (IBB) in Q4 2017: 18,747 shares worth $2M. The stake represents 2.4% of the portfolio and ranks #17 among its holdings.

624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • MPI Investment Management held 18,747 shares of iShares Biotechnology ETF worth $2M as of Q4 2017.
  • iShares Biotechnology ETF was a new MPI Investment Management position in Q4 2017.
  • iShares Biotechnology ETF made up 2.4% of MPI Investment Management's portfolio in Q4 2017, its #17 holding.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on MPI Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.